期刊文献+

免疫系统在癌症治疗中的两面性 被引量:1

下载PDF
导出
作者 李莹
出处 《现代预防医学》 CAS 北大核心 2006年第9期1565-1567,共3页 Modern Preventive Medicine
关键词 免疫系统 癌症
  • 相关文献

参考文献23

  • 1Dunn GP, Old LJ, Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21(2): 137-48. 被引量:1
  • 2Glenn Dranoff: Cytkines In Cancer Pathogenesis and Cancer Therapy Nature Reviews [J]. Cancer, 2004, (4) 11-22. 被引量:1
  • 3徐明曦,应俊,姚德鸿,江鱼.膀胱癌免疫治疗进展[J].国外医学(泌尿系统分册),2003,23(3):273-276. 被引量:2
  • 4Lyerly HK: Quantitating cellular immune responses to cancer vaccines [J]. Semin Oneol 2003, 30 (3 Suppl 8) : 9- 16. 被引量:1
  • 5Nicchitta CV: Re - evaluating the role of heat - shock protein -peptide interactions in tumour immunity [J]. Nat Rev Immunol 2003, 3 (5): 427-432. 被引量:1
  • 6张丹,杨成章.18例头颈部非霍奇金淋巴瘤临床分析[J].临床耳鼻咽喉科杂志,2003,17(9):513-515. 被引量:12
  • 7金光辉.肿瘤的免疫基因治疗[J].网络免疫学文摘,2005,4. 被引量:1
  • 8钟宜芹.Herceptine(Trastuzumab)用于乳癌之治疗(电子期刊)[J].奇美药讯,2004,75. 被引量:1
  • 9Blattman JN, Greenberg PD: Cancer immunotherapy: a treatment for the masses [J]. Science 2004. 305 (5581): 200 - 5. 被引量:1
  • 10Liu K, Iyocla T, Saternus M, Kimura Y, lnaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic calls in situ. Laboratory of Cellular Physiology and Immunology,Chris Browne Center for Immunology and Immune Diseases. The Rockefeller University, New York, NY 10021, USA [J]. J Exp Med 2002, 196 (8): 1091-7 被引量:1

二级参考文献38

共引文献39

同被引文献20

  • 1李国玲,林华笙,韩雪飞,等.恶性肿瘤患者的免疫学变化[J].中华临床新医学,2 0 0 4 ,4 (1 ):9-10. 被引量:1
  • 2de Visser KE, Coussens LM. The interplay between innate andadaptive immunity regulates cancer development[J]. CancerImmunol Immunother,2005,54(11):1143-4452. 被引量:1
  • 3Malmberg KJ. Effective immunotherapy against cancer: aquestion of overcoming immune suppression and immune escape[J]. Cancer Immunol Immunother,2004,53:879-892. 被引量:1
  • 4Mamessier E , Sylvain A , Bertucci F , et al. Human breasttumor cells induce self-tolerance mechanisms to avoid NKG2Dmediatedand DNAM-mediated NK cell recognition[J]. CancerRes,2011,71(21):6621-6632. 被引量:1
  • 5Ito N , Nakamura H , Metsugi H , et al. Dissociation between Thelper type 1 and type 2 differentiation and cytokine productionin tumor-infiltrating lymphocytes in patients with lung cancer[J].Surg Today,2001,31(5):390-394. 被引量:1
  • 6Mahajan R ,El-Omar EM, Lissowska J , et al. Geneticvariants in T helper cell type 1 , 2 and 3 pathways and gastriccancer risk in a Polish population[J]. Jpn J Clin Oncol,2008,38(9):626-633. 被引量:1
  • 7Sun Y , Qian C , Peng D , et al. Gene transfer to liver cancercells of B7-1 plus interleukin 12 changes immunoeffectormechanisms and suppresses helper T cell type 1 cytokineproduction induced by interleukin 12 alone[J]. Hum GeneTher,2000,11(1):127-138. 被引量:1
  • 8De Monte L , Reni M, Tassi E , et al. Intratumor T helper type2 cell infiltrate correlates with cancer-associated fibroblastthymic stromal lymphopoietin production and reduced survival inpancreatic cancer[J]. J Exp Med,2011,208(3):469-478. 被引量:1
  • 9Ehi K , Ishigami S , Masamoto I , et al. Analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells of sentinellymph nodes in breast cancer[J]. Oncol Rep,2008,19(3):601-607. 被引量:1
  • 10Miyazaki T , Liu ZJ, Kawahara A , et al. Three distinct IL-2signaling pathways mediated by b cl-2,c-m yc, and lckcooperate in hematopoietic cell proliferation[J]. Cell,1995,81(2):223-231. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部